Within the category of In Vitro Diagnostic (IVD) devices, IVD consumables are projected to experience the highest compound ...

The "A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU (European Union) and UK Training Course (Apr 29, 2026)" training has been added to ResearchAndMarkets.com's ...

IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...

At its J.P. Morgan Conference 2026 presentation, Qiagen NV alluded to positive full-year results for 2025 and expressed that ...

DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer ...

Medical Devices includes a session from a regulatory expert on how companies can align their research between regions.

Great Britain is entering a new era of MedTech regulation, with major pre-market changes expected that are designed to ...

The global market for contract manufacturing of medical devices is estimated to grow from $96.4 billion in 2025 to reach $155.2 billion by 2030, at a compound annual growth rate (CAGR) of 10% from ...

Oxford Nanopore Technologies today announces that the GridIONtm Dx is now both CE and UKCA marked, making it the company's ...

A rapidly expanding sector integrating advanced technologies like EHRs, telemedicine, and clinical decision support systems ...

MSMEs need handholding to implement online submission of CDSCO mandated WHO-GMP CoPP: BDMAI: Shardul Nautiyal, Mumbai Monday, January 12, 2026, 08:00 Hrs [IST] Pharma MSMEs need a ...

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic ("IVD") device in the UK and Europe: the GridION Dx. Oxford Nanopore Technologies today ...